stella
beta
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study — Stella
Recruiting
Back to Colorectal Cancer Metastatic trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov